![藥理學教學課件:Chapter 19 Analgesics_第1頁](http://file4.renrendoc.com/view/a68ee99c6b85112398f8798db4dac89a/a68ee99c6b85112398f8798db4dac89a1.gif)
![藥理學教學課件:Chapter 19 Analgesics_第2頁](http://file4.renrendoc.com/view/a68ee99c6b85112398f8798db4dac89a/a68ee99c6b85112398f8798db4dac89a2.gif)
![藥理學教學課件:Chapter 19 Analgesics_第3頁](http://file4.renrendoc.com/view/a68ee99c6b85112398f8798db4dac89a/a68ee99c6b85112398f8798db4dac89a3.gif)
![藥理學教學課件:Chapter 19 Analgesics_第4頁](http://file4.renrendoc.com/view/a68ee99c6b85112398f8798db4dac89a/a68ee99c6b85112398f8798db4dac89a4.gif)
![藥理學教學課件:Chapter 19 Analgesics_第5頁](http://file4.renrendoc.com/view/a68ee99c6b85112398f8798db4dac89a/a68ee99c6b85112398f8798db4dac89a5.gif)
版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領
文檔簡介
1Chapter19Analgesics2paintwocomponentssomaticsensationaffective(emotion)1.ConceptSection132.PaintransmissionpathwayNoxiousstimuliPGsK+、H+BK5-HTPrimaryafferentfibres(C/Aδ)nociceptorSpinalcordLimbicsystemSomato-sensorycortexmoodeffect,theaffectiveaspectofpainthesensoryaspectofpainMedullaMidbrainDorsalhorn4DescendingpaininhibitorypathwaysLocalinhibitoryinterneuroninspinalcordPainAscendingpaintransmissionpathwaysEndogenousopioidpeptides5
MedullaMidbrainCortex
Spinal
cordDorsalhornVentralcaudalthalamusPGsK+、H+BK5-HTNSAIDsLocalanestheticsOpioidanalgesics,AntidepressantsandGeneralanaestheticsSitesofactionofdifferentdrugs62.Paina.Acutepain(sharppain):superficialpain,quickresponseofsuddenonset,conductedbyAnervefibersb.Chronicpain(dullpain):morelingeringandaching,conductedbyCnervefibers7severe,sharppainopioidanalgesics(eg.Morphine)inflammation,elevatedtemperature,chronic-dullpainNSAIDs(eg.Aspirin)smoothmusclecolic(eg.biliaryorrenalcolic)
anginapectorisinducedbycoronaryarteryspasm
trigeminalpain3.Durgtreatmentofpaincholinoceptor-blockingdrugs(eg.Atropine)vasodilatordrugs(eg.Nitroglycerin)
Carbamazepine8AnalgesicsDrugswhichactonCNS,couldrelieveoralleviateseverepainandunhappymoodwithoutaffectingothersenseperception,andconsciousness.1.Concept9FullagonistofopioidreceptorsPartialagonistofopioidreceptorsOtheranalgesics2.Classification10Section2FullagonistofopioidreceptorsHistoryofAnalgesicsIn1803,Serturnerisolatedapureactivealkaline---Morphine.In1962,ChinesepharmacologistsproposedtheanalgesicsiteofopioidsislaminaeIIIofperiventricularandperiaqueductalgraymater.Inearly70’,Opioidreceptorsfoundandsuccessfulclonedin1993In1975,firstendogenousOpioidpeptide(endorphin,內(nèi)啡肽)wasfound.1992~1993197319621975
analgesicsiteislaminaeIIIofperiventricularandperiaqueductalgrayareaputforward“receptors”foropiateanalgesicsinbrainisolatedthefirst“endogenousopioidpeptide”andnamedenkephalin腦啡肽clonedthreeopioidreceptors:μ
κ
δResearchonanalgesicmechanismsSubstancePandendogenous
analgesicsystemSubstancePisaneuropeptide:ashort-chainpolypeptidethatfunctionsasaneurotransmitterandasaneuromodulator.
SubstancePisinvolvedinthetransmissionofpainimpulsesfromperipheralreceptorstothecentralnervoussystem.17enkephalinsPresynapticterminalPostsynapticneuronThecellularmechanismsofanalgesiamorphine18
Presynapticinhibition:activationofopioidreceptorsonpresynapticnerveterminals.Closeavoltage-gatedCa2+channel,decreaseCa2+input,andtherebyreducetransmitterrelease.ThecellularmechanismsofanalgesiaPostsynapticinhibition:activationofpostsynapticopioidreceptors.OpenK+channelsonpostsynapticneurons,increaseK+output,andtherebycausehyperpolarizationandthusinhibitpostsynapticneurons.19SpinalcordDorsalhornenkephalinsCa2+Ca2+谷氨酸神經(jīng)肽PresynapticterminalPostsynapticneuronenkephalins
AMPA受體:α-氨基-3-羥基-5-甲基-4-異惡唑丙酸受體NK1:P物質神經(jīng)激肽121SitesofanalgesiaSupraspinal脊椎areas:thalamus丘腦,periventricular,
periaqueductalgrayareaSpinalcord:substantiagelatinosa脊髓膠狀質22EndogenousopioidpeptidesThreemainfamilies:
Enkephalinsmet-enkephalinleu-enkephalin
Endorphins:β-endorphine
Dynorphins強啡肽:
dynorphineA,BEndogenousOpioidPeptidesOpiodsproduceeffectsthatmimictheactionofendogenouspeptideneurotransmitters(1)Endorphins(內(nèi)啡肽類):M-enkephalin(甲硫氨酸腦啡肽),L-enkephalin(亮氨酸腦啡肽),β-endorphin(β-內(nèi)啡肽)(2)Enkephalins(強啡肽類):dynorphineADistributionandfunction
ofopioidreceptors(1)Opioidreceptorsatthalamic,laminaeI,II,III(substantiagalatinosa脊髓膠質區(qū))ofspinalcordandperiventricularandperiaqueductalgraymatter.relatedtotheintergretion,perception,reactionandsensationofpain.(2)Opioidreceptorsatlimbicsystemincludinglocusceruleus(藍斑),anteriortemporalandorbital(前顳與眶)frontalcortexpartsofhypothalamusandamydala(杏仁).involvedinemotion,psychitricactivity,mayberelatedtoeuphoria,toleranceanddependence.(3)Opioidreceptoratnucleussolitarius(孤束核)isthelocationofcoughcenter.(4)Opioidreceptoratareapostremaofmedulla
isthechemoceptortriggerzonegoverningnauseaandemesis.TypesofopioidreceptorsThemajoreffectsoftheopioidsaremediatedby4familiesofreceptors,designatedbyμ、κ、σandδ,eachofwhichexhibitsadifferentspecificityforthedrugsitbinds.Fourmajoropioidreceptors:(1)μ(mu)-receptorsTheanalgesicpropertiesoftheopioidsareprimarilymediatedbytheμ-receptor,andforsomemajorunwantedeffects(e.g.respiratorydepression,euphoria,sedationanddependence).Mostoftheanalgesicopioidsareμ-receptoragonist.μ-receptorisdividedinto1and2subtypes,involvinginsupraspinalanalgesia,respiratoryinhibition,euphoria,physicaldependenceandmiosis.(2)δ(delta)-receptorsareprobablymoreimportantintheperipherybutmayalsocontributetoanalgesia.
-receptorisdividedinto1and2subtypes,involvedinspinalanalgesia,respiratorydepression,euphoria,physicaldependence.(3)κ(kappa)-receptorscontributetoanalgesiaatthespinallevelandmayelicitsedation,dysphoria(焦慮)andmiosis.producerelativelyfewunwantedeffectsanddonotcontributetodependence.Someanalgesicsarerelativelyκselectively.(4)σ(sigma)-receptors
arenottrueopioidreceptorsbutarethesiteofactionofcertainpsychotomimeticdrugs,towhichsomeopioidsalsobind.involvinginanalgesia,dysphoria(焦慮),hallucination,cardiacinhibition,miosis.33Opioidreceptorssupraspinalanalgesia,
sedation,euphoria,respiratorydepression,miosis,
dependencespinalanalgesia,sedationdysphoria,hallucinationspinalanalgesia,
respiratorydepression,sedation,euphoria,dependence
*
:
:
::Subtypesandeffectsofopioidreceptors
:excitation
:inhibitionST
effects
pain
resp
HR-
BP-
pupil
?
Table.functionaleffectsassociatedwiththemaintypesofopioidreceptor
μδκanalgesia
Supraspinal+++--Spinal+++++Peripheral
++-++Respiratorydepression+++++-Pupilconstriction++-+ReducedGImotility+++++euphoria+++--dysphoria--+++sedation++-++Physicaldependence+++-+SignalTransduction
AllopioidreceptorsarecoupledtoinhibitoryG(Gi)proteinsandinhibitadenylylcyclase(AC).TheymayalsobeassociatedwithionchannelstoincreaseK+efflux(hyperpolarization)orreduceCa2+influx,thusimpedingneuronalfiringandtransmitterrelease.37ExtracellularCytoplasmicNH2HOOCOpioid
receptorsGprotein-coupledreceptorsClassifications:
--Opiates:
papaverine罌粟堿,morphine,codeine--Syntheticcompounds--AdditionalanalgesicsAnalgesicsCharacteristics①Potencyanalgesia②Dependence--narcotic(麻醉)analgesics--addictionanalgesics--opioidanalgesics40
Theflowerofpapaversomniferum41Opium421803Serturnerisolatedapureactivealkalinesubstancefromopium.Heproposedthename“morphine”foritafterMorpheus.Morphine43Structure-activityrelationship海洛因嗎啡納洛酮OH44Pharmacokineticsabsorptionexcretiondistribution
freedrugoralFirstpasseliminationsc.im.bloodliverplacental
fetuslittlecrosstheBBB,butenoughforitsfunctionmetabolismmorphine-6-glucuronidekidney,
breast45PharmacologicalactionsCNSSmoothmuscles3.Cardiovascularsystem4.Others46Pharmacologicalactions1.CNSeffects:principaleffectsanalgesiaeuphoriasedationrespiratorydepression
tolerance47(1)Analgesiapowerfulpain-relievingeffectalltypesofpains:*constant,dull﹥intermittent,sharp(easyaddiction)poorefficiencyonneuropathicpain
withoutaffectingconsciousnessandothersenseperception
duration:4-5h
1.CNS48
(2)Sedationandeuphoria
toleranceofpaindrowsinessandcloudingofmentation
sleepinducedandarousedeasily
*Euphoria
asenseofcontentmentandwell-being
relieveanxietyanddistress
Sedationthemainreasonfordrugabuse49Activatetheopioidreceptoratlimbicsystemandlocusceruleus(藍斑)Mechanisms:50
respiratoryrate,tidalvolume
occursatordinarydoses,
dose-related
themostcommoncauseofdeathfromacutepoisoningMechanisms:thesensitivityofrespiratorycentertoincreasedCO2tensionrespiratorymodulatorycenter(3)Respiratorydepression51PulmonaryedemadyspneaAcuteleftventriculardysfunctionshortofbreath(respiratorycenter)
CO2retentionanxietyanddistressAlveolarhypoventilation
morphineReducecardiacpreloadandafterloadReducethesensitivityoftherespiratorycentertoincreasedCO2SedationCardiacasthma
andmorphinetherapy
53
(4)Coughsuppressionbyinhibitingcoughcenterdirectly
Hasantitussiveeffect54
(5)Miosis:
pinpointpupils
ischaracteristicofacutepoisoningblockedbynaloxoneandatropineNauseaandvomiting:
activatethebrainstemCTZ
55(6)Others
↓releaseofgonadotropin-releasinghormone(GnRH)↓releaseofcorticotropin-releasinghormone(CRF)↓concentrationofluteinizinghormone(LH),folliclestimulatinghormone(FSH)↓adrenocorticotropichormone(ACTH)↑prolactinrelease56Pharmacologicalactions2.SmoothMuscleStimulating
GastrointestinalsystemBiliarytractUrinaryBronchia57(1)Gastrointestinaltract
delayspassage2.Smoothmusclesystem
secretionofdigestiveglandindigestioncentralinhibition
acallofnaturedefecationreflexsphinctertoneGITtone
GITmotilityabsorptionofwaterconstipationClinicaluses?58
biliarycolic
constrictbiliarysmoothmuscleconstrictOddi'ssphincterpressureinthebiliarytract(2)BiliarytractMedicine?59(3)Othersmoothmuscle
①constrict
ureteralsmoothmuscleconstrictbladdersphincterurinaryretention
③antagonize
oxytocin(縮宮素)
uterinetone
prolonglabor
②constrictbronchialsmoothmusclebronchial
asthma
60
orthostatichypotensionMechanisms:
releaseofhistaminevasomotorcenter3.Cardiovascularsystem(1)peripheralarterialandvenousdilatation(2)intracranialpressuresecondarytorespiratorydepression614.Otheractionsinhibitimmunesystem
histaminerelease
bronchospasmflushingarteriolardilatation62ClinicalusesAnalgesia
acute,severepain,particularlyin
terminalcancermyocardialinfarctionrenalandbiliarycolic(atropine)short-termuseonlywhenothersfailed2.*Cardiacasthma
3.Antidiarrhea63PulmonaryedemadyspneaAcuteleftventriculardysfunctionshortofbreath(respiratorycenter)
CO2retentionanxietyanddistressAlveolarhypoventilationmorphineReducecardiacpreloadandafterloadReducethesensitivityoftherespiratorycentertoincreasedCO2SedationCardiacasthma
andmorphinetherapy
64(1)Mechanisms:①
peripheralarterialandvenousdilationpreloadandafterloadpulmonaryedema②
sedation
anxietyanddistress
oxygenconsumption
③
thesensitivityofrespiratorycenterto
CO2
shortnessofbreathCardiacasthma651.Generaladverseeffects1dysphoria5Biliarycolic2Respiratorydepression6Urinaryretention3Nauseaandvomiting7Posturalhypotensionaccentuatedbyhypovolemia4Constipation8IncreasedintracranialpressureAdverseeffects662.AcuteMorphinePoisoning673.Toleranceanddependence(1)Tolerance
agraduallossineffectivenessinCNSwithfrequentlyrepeatedadministration,needlargerdosestoachievethesameclinicaleffect.
Characteristic:
ordinarytherapeuticdoses2-3wlargedosesatshortintervalsreadily
developnottomiosis,constipation68
physicaldependence:
withdrawalsyndromepsychologicaldenpendence:euphoriapromotecompulsiveuseandcraving(2)Dependence69戒斷綜合癥狀
SYMPTOMSOFWITHDRAWAL腹瀉出汗抑郁震顫衰弱肌痙攣寒戰(zhàn)渴求藥物頭痛、嗎啡與藍斑核μ受體結合后,NA能神經(jīng)元受抑制71
rhinorrhealacrimation
chills
gooseflesh(piloerection)yawningsweatingmuscularachesvomitingdiarrhea
anxiety
hostilityhyperventilation
Withdrawal
syndromeofOpioid72Contraindications
reasonsthatresultinpainarenotclear
obstetriclabor,breastingperiod
corpulmonale,bronchialasthma
headinjuries
seriouslyimpairedhepaticorrenalfunction
newborninfant,infant
biliaryandrenalcolic73Codeine(methyl-morphine)Characteristics:1.hasahigher
oralefficacy
2.weakeranalgesia,about1/10-1/12,antitussive:1/43.usedinmoderatepain4.mailyuseasantitussive,severe
drycough.
74Pethidine(dolantin,meperidin)
analgesia:weaker(1/7-1/10)andshorter(2-4h)sedation,euphoria,respiratorydepression:equal
noantitussiveactionMetabolismsnormeperidine
muscle
tremors,witches,convulsion2.Pharmacologicalproperties(1)CNS75(3)Cardiovascularsystem
similartomorphine(2)Smoothmuscle
lessconstipationandurinaryretention
donotprolonglabor
mayinducebiliarycolic
largedosesthecontractionofbronchialsmoothmuscle763.Clinicaluses(1)Analgesiaobstetriclabor
but
shouldnotbeusedin2-4hbeforelabor
donotlongtimeuseinchronicpain.
(2)Cardiacasthma(3)Premedicationinanesthesia
sedative,anxiolytic,andanalgesia77
(4)Artificialhibernation
pethidinechlorpromazinepromethazinelyticcocktailⅠ4.AdverseeffectsCNSexcitatorysymptoms
muscletremors,twitches,convulsion
shouldbecombinedwithanticonvulsive
drugswhentreatoverdosepoisoning(2)somesymptomslikeatropine78IncreasedCNSdepression,particularlyrespiratorydepressionOpioidanalgesics
MAOIsTricyclicantidepressantschlorpromazinepromethazineSedative-hypnoticsAbsolutecontraindicationtopethidine,relativecontraindicationtootheropioidanalgesics,becauseofhighincidenceofhyperpyreticcomaDrug–Druginteractions79Methadone美沙酮Characteristics:
1.analgesia:equaltomorphine2.givereliableeffectsorally,longerdurationofaction3.toleranceandphysicaldependencemoreslowly4.withdrawalsignsattenuatedbutprotracted5.detoxificationofthemorphineandheroindependentaddict80Fentanyl
Characteristics:
1.moreanalgesicpotentcythanmorphine:100times2.hasarapidonsetandshortdurationofaction
3.highlipid-soluble,transdermaladministration4.+droperidol(氟哌利多)
neuroleptanalgesia(神經(jīng)阻滯鎮(zhèn)痛術)
orusuallycombinedwithanaesthetics5.highdosecausetruncalrigidity81ShortactingfentanylsufentanilalfentanilAgonistsmixedAgonists/AntagonistsAntagonists
WEAK:codeinepentazocineSTRONG:methadonemorphine
pethidine
buprenorphinenalbuphinelongactingnaltrexonenaloxoneClassificationofopioidanalgesics82
Section3Partialagonistsofopioidreceptor
83Pentazocine噴他佐辛Characteristic:
κ,σagonist,μweakantagonist
1.CNSanalgesia:1/3respiratorydepression:1/2*psychomimeticaction(60-90mg)
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025至2030年企業(yè)信息門戶項目投資價值分析報告
- 生麻生產(chǎn)項目風險識別與評估綜合報告
- 生物質碳化專用爐項目風險評估報告
- 2025年度城市智慧照明系統(tǒng)采購與安裝合同
- 2025年度新能源發(fā)電項目承包合同書
- 2025年度合同管理云平臺年度服務合同
- 2025年度建筑工程返點與施工團隊協(xié)作合同
- 2025年度冷鏈物流專用車輛租賃及冷鏈管理服務合同
- 2025年度健康醫(yī)療居間行紀合同細則
- 2025年度區(qū)塊鏈技術應用合作經(jīng)營合同范本
- 2025福建新華發(fā)行(集團)限責任公司校園招聘30人高頻重點提升(共500題)附帶答案詳解
- 油氣長輸管道檢查標準清單
- 山東鐵投集團招聘筆試沖刺題2025
- 圖像敘事的跨學科視野-洞察分析
- 急性缺血性卒中再灌注治療指南2024解讀
- 暑假假期安全教育(課件)-小學生主題班會
- 2025年中考英語總復習:閱讀理解練習題30篇(含答案解析)
- 陜西省英語中考試卷與參考答案(2024年)
- 中建醫(yī)院幕墻工程專項方案
- 基于OBE理念的世界現(xiàn)代史教學與學生歷史思維培養(yǎng)探究
- 施工現(xiàn)場揚塵污染治理巡查記錄
評論
0/150
提交評論